imipramine has been researched along with Dyspepsia in 3 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Dyspepsia: Impaired digestion, especially after eating.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between Sept 11, 2005, and Aug 20, 2010, 107 patients with treatment-refractory functional dyspepsia were randomly assigned to receive imipramine (n=55) or placebo (n=52)." | 9.27 | Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. ( Chan, FKL; Chan, Y; Cheong, PK; Cheung, CKY; Ching, JYL; Ford, AC; Sung, JJY; Wu, JCY, 2018) |
| "Between Sept 11, 2005, and Aug 20, 2010, 107 patients with treatment-refractory functional dyspepsia were randomly assigned to receive imipramine (n=55) or placebo (n=52)." | 5.27 | Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. ( Chan, FKL; Chan, Y; Cheong, PK; Cheung, CKY; Ching, JYL; Ford, AC; Sung, JJY; Wu, JCY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, T | 1 |
| Moayyedi, P | 1 |
| Cheong, PK | 1 |
| Ford, AC | 1 |
| Cheung, CKY | 1 |
| Ching, JYL | 1 |
| Chan, Y | 1 |
| Sung, JJY | 1 |
| Chan, FKL | 1 |
| Wu, JCY | 1 |
| Teitelbaum, JE | 1 |
| Arora, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial[NCT00164775] | Phase 3 | 107 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for imipramine and Dyspepsia
| Article | Year |
|---|---|
Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Dyspepsia; Female; Gastrointestinal Ag | 2018 |
2 other studies available for imipramine and Dyspepsia
| Article | Year |
|---|---|
Imipramine for functional dyspepsia: a 60-year journey.
Topics: Double-Blind Method; Dyspepsia; Gastritis; Helicobacter Infections; Humans; Imipramine | 2018 |
Long-term efficacy of low-dose tricyclic antidepressants for children with functional gastrointestinal disorders.
Topics: Abdominal Pain; Adolescent; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Child, Preschool | 2011 |